Value | Commercial | Access

Apersy provide flexible support to bring the payer point of

view to your development programme

Extensive experience, unique expertise

Seeing pricing and market access from all sides: experience working for different stakeholders

  • CROs
  • Investment management
  • NGOs/think tanks
  • Big pharma
  • Biotech
  • Start-ups & techtransfer

However novel your product or particular your situation, weird and wonderful is our bread and butter.

  • Digital medical devices / healthcare AI
  • Connected diagnostics
  • Microbiome products
  • Combination products
  • Advance therapies
  • Orphan drugs

Focus expertise on European markets

Healthcare systems, payers and insurance, reimbursement processes and HTA requirements, agencies, …

Collaborating differently

Being part of your team, intermediary, mentor, expert;

Finding the perfect development experts and partners for your needs;

Network within the healthcare and product development space.

Henrike Granzow, MSc

Market access expert, Health economist by training, with over 14 years of experience in Life Science strategy consultancies, investment management, clinical research organisations and health policy.

My core expertise lies in strategy for product shaping, evidence generation planning, market access strategy and pricing strategy. I build on working experience in Germany, the UK, Switzerland, Spain and France for a holistic view on Europe, the major European healthcare systems and reimbursement processes. Whether it’s pricing & access, investors, business model, launch or life-cycle, I am currently focused on novel technologies, such as digital and connected medical devices and diagnostics, innovative biotech, oncology and advanced therapies.

Special topics: Product strategy, multi-indication launches, orphan disease, ATMPs, due diligence, forecasting and portfolio advisory, digital healthcare solutions, diagnostics 

We believe in bringing in the best experts, having the flexibility to provide the right expertise for each project. Relevant relationships and partners present true value for clients.

Whether it’s providing product pricing valuation for a licensing or acquisition deal, developing strong pricing, reimbursement, and access strategies to ensure reimbursement listing and access for patients or assisting firms in their US and global product launches,  Value Genome LLC helps biopharmaceutical firms maximize access to innovative medicines while optimizing revenue streams with win-win solutions.

Cube RM is a global Tender Software and data company that focuses on empowering Life Sciences organizations to accelerate revenue growth. Cube RM’s platforms use AI & NLP to capture and analyze key tender market data globally and transform it into actionable market intelligence, coupled with seamless software automation & industry expertise to increase tender processes efficiency

… and many trusted relationships with complementary expertise

Regulatory; Health Economics; academia; policy; clinical experts and advisors across oncology, GI, radiology; local market experts across European markets and the US; …

Working with Apersy


Your science meets commercial expertise


Connections, management and partnerships


Frameworks, thought processing and training that foster understanding